AF
TCRT icon

Advisornet Financial’s Alaunos Therapeutics TCRT Stock Holding History

Advisornet Financial’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43 Hold
19
– – ﹤0.01% 2245
2026
Q1 		$54 Hold
19
– – ﹤0.01% 2220
2025
Q4 		$61 Hold
19
– – ﹤0.01% 2203
2025
Q3 		$46 Hold
19
– – ﹤0.01% 2211
2025
Q2 		$92 Hold
19
– – ﹤0.01% 2180
2025
Q1 		$28 Hold
19
– – ﹤0.01% 2152
2024
Q4 		$36 Sell
19
-262
-93% -$582 ﹤0.01% 1952
2024
Q3 		$905 Sell
281
-1
-0.4% -$4 ﹤0.01% 1957
2024
Q2 		$1.97K Hold
282
– – ﹤0.01% 1643
2024
Q1 		$5.11K Hold
282
– – ﹤0.01% 1434
2023
Q4 		$2.99K Hold
282
– – ﹤0.01% 1611
2023
Q3 		$5.58K Hold
282
– – ﹤0.01% 1395
2023
Q2 		$21.6K Hold
282
– – ﹤0.01% 1059
2023
Q1 		$26.7K Hold
282
– – ﹤0.01% 978
2022
Q4 		$27.5K Hold
282
– – ﹤0.01% 954
2022
Q3 		$73K Hold
282
– – 0.01% 739
2022
Q2 		$52K Hold
282
– – 0.01% 858
2022
Q1 		$28K Buy
282
+19
+7% +$2.44K ﹤0.01% 1151
2021
Q4 		$43K Buy
+263
New +$57.8K ﹤0.01% 1065

Other funds holding TCRT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
AIM
Axiom Investment Management New York $150M AUM
KFI
Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return

Advisornet Financial's TCRT Position: Q2 2026 in Review

Advisornet Financial held its Alaunos Therapeutics (TCRT) position steady in Q2 2026 at 19 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Advisornet Financial first reported a position in TCRT in Q4 2021 and has held it in 19 quarters since. The position peaked at $73K in Q3 2022. 7 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

  • Advisornet Financial held 19 shares of Alaunos Therapeutics worth $43 as of Q2 2026.
  • Advisornet Financial left its Alaunos Therapeutics share count unchanged in Q2 2026.
  • Alaunos Therapeutics made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #2245 holding.
  • Advisornet Financial first reported a position in Alaunos Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Advisornet Financial's Alaunos Therapeutics position peaked at $73K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.